Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum.
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
6
3
2021
Statut:
epublish
Résumé
[This corrects the article DOI: 10.7150/thno.23177.].
Identifiants
pubmed: 33664874
doi: 10.7150/thno.58558
pii: thnov11p3963
pmc: PMC7914359
doi:
Types de publication
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
3963Commentaires et corrections
Type : ErratumFor
Informations de copyright
© The author(s).